MiR-183-5p is required for non-small cell lung cancer...

Biomedicine & Pharmacotherapy 2019 / 03 Vol. 111

MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN

Wang, Huimin, Ma, Zhongliang, Liu, Xiaomin, Zhang, Caiyan, Hu, Yanping, Ding, Lei, Qi, Pengfei, Wang, Ju, Lu, Shengdi, Li, Yanli
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
111
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2018.12.115
Date:
March, 2019
File:
PDF, 3.34 MB
2019
Conversion to is in progress
Conversion to is failed